AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2023
Mar 31, 2023
31949_dirs_2023-03-31_e7e162c5-c68b-4ad3-a6e2-95a0b23ebf00.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2023-03-28
Reporting Person: Stafford Kristin (N/A)
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3